Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
MDS Network Plots
<p>Two sources:</p> <ul> <li>Video of network change</li> <li>Individual network plot, which compose the video</li> </ul> <p> </p>
Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDS
ClinicalTrials.gov study NCT01617226. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS
ClinicalTrials.gov study NCT04849910. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT
ClinicalTrials.gov study NCT02472691. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02319369. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00854646. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02942290. IPD Sharing: NO. Countries: 7. Publications: 1.
Enhanced Palliative Care in MDS and AML
ClinicalTrials.gov study NCT04226768. IPD Sharing: NO. Countries: 1. Publications: 25.
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
ClinicalTrials.gov study NCT03310918. IPD Sharing: NO. Countries: 1. Publications: 1.
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
ClinicalTrials.gov study NCT02494167. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk
ClinicalTrials.gov study NCT00906334. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
ClinicalTrials.gov study NCT04602273. IPD Sharing: UNDECIDED. Countries: 1. Publications: 17.
Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
ClinicalTrials.gov study NCT00043381. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
ClinicalTrials.gov study NCT00687323. IPD Sharing: YES. Countries: 0. Publications: 1.
This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.
ClinicalTrials.gov study NCT01250951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS
ClinicalTrials.gov study NCT00744536. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
ClinicalTrials.gov study NCT02985190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety, Tolerability, and Efficacy of Deferasirox in MDS
ClinicalTrials.gov study NCT00469560. IPD Sharing: NO. Countries: 1. Publications: 8.
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
ClinicalTrials.gov study NCT00854945. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
ClinicalTrials.gov study NCT00761722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.